Lv31
268 积分 2025-05-01 加入
Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa
13分钟前
已完结
Porous Silicon Nanoneedles Efficiently Deliver Adenine Base Editor to Correct a Recurrent Pathogenic COL7A1 Variant in Recessive Dystrophic Epidermolysis Bullosa
14分钟前
待确认
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial
14分钟前
已完结
Safe and Efficacious Permanent Removal of Large COL7A1 Exons for Gene Reframing as a Reliable Therapeutic Strategy for Recessive Dystrophic Epidermolysis Bullosa
15分钟前
求助中
Highly efficient ex-vivo correction of COL7A1 through RNP-based CRISPR/Cas9 and Homology-Directed Repair to treat recessive dystrophic epidermolysis bullosa
16分钟前
已完结
Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa
16分钟前
已完结
Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study
17分钟前
已完结
Decoding COL7A1: A Genetic Roadmap to Prognostication and Personalised Medicine in Recessive Dystrophic Epidermolysis Bullosa
18分钟前
已完结
Genotype-Phenotype Correlations in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review
19分钟前
已完结
Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study
9小时前
已完结
皖公网安备34019202002308
